In AD animal models, it was shown that chronic intracerebroventricular (icv) injection of Aβ in rats provoked a significant enhancement of both B1R and B2R binding sites, mainly in brain regions associated with cognitive behavior [28]. This evidence concerns the gene BDKRB2 and Alzheimer disease.